New Methods for ALK Status Diagnosis in Non-Small-Cell sorted by
relevance

Admin24.08.2021

New Methods for ALK Status Diagnosis in Non-Small-Cell

7201
Admin27.09.2021

Crizotinib for ALK-Rearranged Non-Small Cell Lung Cancer

Admin20.09.2021

New Methods for ALK Status Diagnosis in Non-Small-Cell

9408
Admin07.08.2021

Biopsy and Mutation Detection Strategies in Non-Small Cell

5404
Admin28.07.2021

New Methods for ALK Status Diagnosis in Non-Small-Cell

4906
Admin17.07.2021

Diagnostic algorithm for molecular testing of small bio

3301
Admin09.10.2021

(PDF) Biopsy and Mutation Detection Strategies in Non

9404
Admin26.08.2021

Prevalence of driver mutations in non-small-cell lung

7706
Admin16.09.2021

Incidence and survival of non-small cell lung cancer in

9904
Admin19.09.2021

Figure 2 from New options in the management of intractable

Admin07.10.2021

The Tissue Is the Issue: Personalized Medicine for Non

6707
Admin23.09.2021

Baseline patient characteristics (n 5 216) | Download

9203
Admin02.09.2021

Characteristics of a new EML4-ALK -positive cell line, ABC

53010
Admin10.09.2021

Treatment algorithms for non-small cell lung cancer

4802
Admin05.08.2021

Timeline of targeted therapy development. Abbreviations

9803
Admin03.10.2021

CTC levels at baseline, 2nd and 5th cycle of chemotherapy

6104
Admin29.09.2021

Frontiers | Current Treatment Algorithms for Patients with

2102
Admin17.08.2021

(A) PFS with different systemic treatments dependent on

503
Admin29.08.2021

Status of Anaplastic Lymphoma Kinase (ALK) in Malignant

5600
Admin25.07.2021

Updated guidelines for predictive biomarker testing in

4708
Admin13.08.2021

Therapeutic management of ALK+ nonsmall cell lung cancer